Simvastatin reduces VEGF and NO levels in acute stages of experimental traumatic brain injury

Neurological Sciences

Volumn 34, Issue 11, 2013, Pages 1941-1946

  Yüksel, Hatice ^a   Yavuz, Özlem ^b   Iş, Merih ^c   Çomunoǧlu, Nil ^d   Üzüm, Gülay ^e   Akyüz, Feyzullah ^f   Yildirim, Hayriye Ak ^g  

^a DICLE UNIVERSITY   (Turkey)

^b BALIKESIR UNIVERSITY   (Turkey)

^c DR LUTFI KIRDAR KARTAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^e ISTANBUL UNIVERSITY   (Turkey)

^f Duzce Ataturk State Hospital   (Turkey)

^g Department of Biochemistry   (Turkey)

Author keywords

NO; Rat; Simvastatin; Traumatic brain injury; VEGF

Indexed keywords

NITRIC OXIDE; SIMVASTATIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BRAIN LEVEL; CONTROLLED STUDY; DIFFUSE AXONAL INJURY; DISEASE COURSE; DOSE RESPONSE; DRUG MECHANISM; HISTOPATHOLOGY; LOW DRUG DOSE; MALE; NEUROPROTECTION; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; SINGLE DRUG DOSE; TRAUMATIC BRAIN INJURY;

ACUTE DISEASE; ANIMALS; ANTICHOLESTEREMIC AGENTS; BRAIN INJURIES; MALE; NITRIC OXIDE; RATS; RATS, WISTAR; SIMVASTATIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84888289692     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-013-1411-z     Document Type: Article

References (33)

1. Maas AIR, Stocchetti N, Bullock R (2008) Moderate and severe traumatic brain injury in adults. Lancet Neurol 7:728-741
2. Xiong Y, Gu Q, Peterson PL, Muizelaar JP, Lee CP (1997) Mitochondrial dysfunction and calcium perturbation induced by traumatic brain injury. J Neurotrauma 14:23-34
3. Smith SL, Andrus PK, Zhang JR, Hall ED (1994) Direct measurement of hydroxyl radicals, lipid peroxidation, and blood-brain barrier disruption following unilateral cortical impact head injury in the rat. J Neurotrauma 11:393-404
4. Hall ED (1993) Lipid antioxidants in acute central nervous system injury. Ann Emerg Med 22:1022-1027
5. Kontos HA, Povlishock JT (1986) Oxygen radicals in brain injury. Cent Nerv Syst Trauma 3:257-263
6. Iadecola C (1997) Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 20:132-139
7. Kostandy BB (2012) The role of glutamate in neuronal ischemic injury: the role of spark in fire. Neurol Sci 33:223-237
8. Hall ED, Kupina NC, Althaus JS (1999) Peroxynitrite scavengers for the acute treatment of traumatic brain injury. Ann N Y Acad Sci 890:462-468
9. Lipton SA, Choi YB, Pan ZH, Lei SZ, Chen HS, Sucher NJ, Loscalzo J, Singel DJ, Stamler JS (1993) A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 364:626-632
10. Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029-1039
11. Bates DO, Curry FE (1997) Vascular endothelial growth factor increases microvascular permeability via a Ca(2 +)-dependent pathway. Am J Physiol 273:H687-H694
12. Wu HM, Huang Q, Yuan Y, Granger HJ (1996) VEGF induces NO-dependent hyperpermeability in coronary venules. Am J Physiol 271:H2735-H2739
13. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, Bruggen Nv, Chopp M (2000) VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 106:829-838
14. Faden AI, Stoica B (2007) Neuroprotection: challenges and opportunities. Arch Neurol 64:794-800
15. Liao JK (2005) Clinical implications for statin pleiotropy. Curr Opin Lipidol 16:624-629
16. Işeri S, Ercan F, Gedik N, Yüksel M, Alican I (2007) Simvastatin attenuates cisplatin-induced kidney and liver damage in rats. Toxicology 230:256-264
17. Marmarou A, Foda MA, Van den Brink W, Campbell J, Kita H, Demetriadou K (1994) A new model of diffuse brain injury in rats. Part I: pathophysiology and biomechanics. J Neurosurg 80:291-300
18. Schiessl B, Strasburger C, Bidlingmaier M, Mylonas I, Jeschke U, Kainer F, Friese K (2006) Plasma- and urine concentrations of nitrite/nitrate and cyclic Guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies. Arch Gynecol Obstet 274:150-154
19. Genescà J, Martí R, Rojo F et al (2003) Increased tumour necrosis factor alpha production in mesenteric lymph nodes of cirrhotic patients with ascites. Gut 52:1054-1059
20. Albert-Weissenberger C, Sirén A-L (2010) Experimental traumatic brain injury. Exp Transl Stroke Med 2:16
21. Essig M, Vrtovsnik F, Nguyen G, Sraer JD, Friedlander G (1998) Lovastatin modulates in vivo and in vitro the plasminogen activator/plasmin system of rat proximal tubular cells: role of geranylgeranylation and Rho proteins. J Am Soc Nephrol 9:1377-1388
22. Lu D, Mahmood A, Goussev A, Schallert T, Qu C, Zhang ZG, Li Y, Lu M, Chopp M (2004) Atorvastatin reduction of intravascular thrombosis, increase in cerebral microvascular patency and integrity, and enhancement of spatial learning in rats subjected to traumatic brain injury. J Neurosurg 101:813-821
23. Chen J, Zhang ZG, Li Y et al (2003) Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 53:743-751
24. Urbich C, Dernbach E, Zeiher AM, Dimmeler S (2002) Double-edged role of statins in angiogenesis signaling. Circ Res 90:737-744
25. Mauro VF (1993) Clinical pharmacokinetics and practical applications of simvastatin. Clin Pharmacokinet 24:195-202
26. Wu H, Lu D, Jiang H, Xiong Y, Qu C, Li B, Mahmood A, Zhou D, Chopp M (2008) Increase in phosphorylation of Akt and its downstream signaling targets and suppression of apoptosis by simvastatin after traumatic brain injury. J Neurosurg 109:691-698
27. Chen G, Zhang S, Shi J, Ai J, Qi M, Hang C (2009) Simvastatin reduces secondary brain injury caused by cortical contusion in rats: possible involvement of TLR4/NF-kappaB pathway. Exp Neurol 216:398-406
28. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604-4613
29. Kaur C, Ling EA (2008) Blood-brain barrier in hypoxic-ischemic conditions. Curr Neurovasc Res 5:71-81
30. Mayhan WG (1999) VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway. Am J Physiol 276:C1148-C1153
31. Zhu X-Y, Daghini E, Chade AR, Lavi R, Napoli C, Lerman A, Lerman LO (2008) Disparate effects of simvastatin on angiogenesis during hypoxia and inflammation. Life Sci 83:801-809
32. Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, Buerk DG, Huang PL, Jain RK (2001) Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 98:2604-2609
33. Terpolilli NA, Zweckberger K, Trabold R, Schilling L, Schinzel R, Tegtmeier F, Plesnila N (2009) The novel nitric oxide synthase inhibitor 4-amino-tetrahydro-l-biopterine prevents brain edema formation and intracranial hypertension following traumatic brain injury in mice. J Neurotrauma 26:1963-1975